Biome Australia Launch new product post successful clinical trial
- Biome Australia (BIO) publishes successful acne clinical trial data confirming the efficacy of the company’s targeted probiotic approach to acne treatment
- Results from the clinical trial undertaken in Italy showed the use of the company’s probiotic treatment led to a 31.1 per cent reduction in acne lesions over four weeks
- Following the success of the clinical trial, the company says it is preparing to launch and manufacture a new product for acne treatment called Biome Acne Probiotic
- Biome Acne Probiotic will become available to over 2300 community pharmacies and independent health practitioners across Australia, and will also be launched into the UK and New Zealand markets as “Biome Derma”
- In afternoon trade, shares were trading up 5 per cent at 10 cents
